Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Biogen's high-dose drug for spinal muscular atrophy approved by MHRA

Spinal muscular atrophy (SMA) is a rare, genetic neuromuscular condition caused by altered copies of a gene that prevent the body from producing enough Survival of Motor Neuron protein.

iStock